OS Therapies Management
Management criteria checks 3/4
OS Therapies' CEO is Paul Romness, appointed in Apr 2018, has a tenure of 6.33 years. total yearly compensation is $360.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 11.21% of the company’s shares, worth $9.49M. The average tenure of the management team and the board of directors is 1.6 years and 3.7 years respectively.
Key information
Paul Romness
Chief executive officer
US$360.0k
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 6.3yrs |
CEO ownership | 11.2% |
Management average tenure | 1.6yrs |
Board average tenure | 3.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$8m |
Dec 31 2023 | US$360k | US$360k | -US$8m |
Sep 30 2023 | n/a | n/a | -US$9m |
Mar 31 2023 | n/a | n/a | -US$7m |
Dec 31 2022 | US$360k | US$360k | -US$6m |
Sep 30 2022 | n/a | n/a | -US$6m |
Dec 31 2021 | US$360k | US$360k | -US$8m |
Compensation vs Market: Paul's total compensation ($USD360.00K) is below average for companies of similar size in the US market ($USD691.65K).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Romness (58 yo)
6.3yrs
Tenure
US$360,000
Compensation
Mr. Paul A. Romness, MPH, is Founder, President, Chief Executive Officer and Director of OS Therapies Inc. since April 2018. Prior to founding OS Therapies Inc., Mr. Romness served as a Principal for PR St...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.3yrs | US$360.00k | 11.21% $ 9.5m | |
Chief Medical Officer & Chief Scientific Officer | 4.9yrs | US$300.00k | 1.0% $ 844.0k | |
Chief Financial Officer | 1.1yrs | no data | 0.50% $ 422.0k | |
Chief of Staff | 1.6yrs | no data | no data | |
Chief Business Officer | less than a year | no data | no data |
1.6yrs
Average Tenure
59.5yo
Average Age
Experienced Management: OSTX's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.3yrs | US$360.00k | 11.21% $ 9.5m | |
Non Executive Chairman of the Board | 3.7yrs | US$5.04k | 0.13% $ 110.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 3.7yrs | US$40.00 | 0.10% $ 84.4k | |
Independent Director | 3.7yrs | US$40.00 | 0.10% $ 84.4k | |
Independent Director | 2.1yrs | US$40.00 | no data | |
Member of Patient Advocacy Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific & Medical Advisory Board | no data | no data | no data | |
Member of Scientific & Medical Advisory Board | no data | no data | no data | |
Member of Scientific & Medical Advisory Board | no data | no data | no data | |
Member of Scientific & Medical Advisory Board | no data | no data | no data |
3.7yrs
Average Tenure
44yo
Average Age
Experienced Board: OSTX's board of directors are considered experienced (3.7 years average tenure).